Jiang XiaohuaAssociate Professor

Telephone:  3943 1229

Email:  This email address is being protected from spambots. You need JavaScript enabled to view it.

Website:  https://jiangcynthia.wixsite.com/website

Address:

 Room 409A, 4/F., Lo Kwee-Seong Integrated Biomedical Sci. Bldg., Area 39, CUHK

 

 

  

Biography

Prof. JIANG Xiaohua (蔣曉華) graduated from Shanghai Second Medical University (currently School of Medicine, Shanghai JiaoTong University) and completed her internship and residency at RuiJin Hospital, Shanghai.  She obtained her PhD degree in cell biology from the University of Hong Kong.  Prof. JIANG undertook her postdoctoral training at the Department of Medicine, UCLA.  Her work focused on the role of protein kinase cascades in cancer development.  After that, she joined the University of Southern California as a CIRM (California Institute for Regenerative Medicine) fellow and her research focused on understanding the origin and genetics of Ewing sarcoma by using human embryonic stem cells as an innovative model.  In 2013, she established an independent laboratory within School of Biomedical Sciences at The Chinese University of Hong Kong.  Her major research interest is in stem cell biology and regenerative medicine, in particular, molecular regulation of stem cells, stem cell microenvironment and stem cell therapy in neurological diseases.  Prof. JIANG has published more than 80 peer-reviewed papers with over 3,000 citations and a h-index of 30, including Nature Medicine, Cell Research, Cell Death and Differentiation, Stem Cells, Stem Cell Reports and Cancer Research

  1. Molecular regulation of adult stem cells. 
  2. Stem cell therapy in tissue repair and regeneration. 
  3. Crosstalk between stem cells and environment during aging and age-related diseases.
  4. Disease modeling using pluripotent stem cells.
  1. Wong, T.W., Kan, C.D., Chiu, W.T., Fok, K.L., Ruan, Y., Jiang, X., Chen, J., Kao, C.C., Chen, I.Y., Lin, H.C., Chou, C.H., Lin, C.W., Yu, C.K., Tsao, S., Lee, Y.P., Chan, H.C., & Wang, J.N. (2019). Cardiac Progenitor Cells Derived from Drain Waste Product of Open Heart Surgery in Children. J Clin Med, 12, 8(7).
  2. Yin, C., Wen, G., Liu, C., Yang, B., Lin, S., Huang, J., Zhao, P., Wong, S.H.D., Zhang, K., Chen, X., Li, G., Jiang, X., Huang, J., Pu, K., Wang, L., & Bian, L. (2018) Organic Semiconducting Polymer Nanoparticles for Photoacoustic Labeling and Tracking of Stem Cells in the Second Near-Infrared Window. ACS Nano, 12(12), 12201-12211.
  3. Liu, S., U, K.P., Zhang, J., Tsang, L.L., Huang, J., Tu, S.P., & Jiang, X. (2018). R-spodin2 enhances canonical Wnt signaling to maintain the stemness of glioblastoma cells. Cancer Cell International, 18, 156.
  4. Sun, X., Guo, J.H., Zhang, D., Chen, J.J., Lin, W.Y., Huang, Y., Chen, H., Huang, W.Q., Liu, Y., Tsang, L.L., Yu, M.K., Chung, Y.W., Jiang, X., Huang, H., Chan, H.C., & Ruan, Y.C. (2018). Activation of the epithelial sodium channel (ENaC) leads to cytokine profile shift to pro-inflammatory in labor. EMBO Molecular Medicine, 10(10), pii: e8868.
  5. Yang, F.Y., Chen, R., Zhang, X., Huang, B., Tsang, L.L., Li, X., & Jiang, X. (2018). Preconditioning Enhances the Therapeutic Effects of Mesenchymal Stem Cells on Colitis Through PGE2-Mediated T-Cell Modulation. Cell Transplantation, 27(9), 1352-1367.
  6. Zhang, J., Wang, Y., Jiang, X.*, & Chan, H.C.* (2018). Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer. Cellular and Molecular Life Sciences, 75(10), 1737-1756.
  7. Li, X., Fok, K.L., Guo, J., Wang, Y., Liu, Z., Chen, Z., Wang, C., Ruan, Y.C., Yu, S.S., Zhao, H., Wu, J., Jiang, X.*, & Chan, H.C. (2018). Retinoic acid promotes stem cell differentiation and embryonic development by transcriptionally activating CFTR. Biochim Biophys Acta Mol Cell Res, 1865(4), 605-615.
  8. Lin, S., Lee, W.Y.W., Feng Q., Xu L., Wang, B., Man, G.C.W., Chen, Y., Jiang, X., Bian, L., Cui, L., Wei, B., & Li, G. (2017). Synergistic effects on mesenchymal stem cell-based cartilage regeneration by chondrogenic preconditioning and mechanical stimulation. Stem Cell Res Ther, 8(1), 221.
  9. Chen, K., Liu, Q., Tsang, L.L., Ye, Q., Chan, H.C., Sun, Y., & Jiang, X. (2017). Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway. Cell Death Dis, 8(5), e2819.
  10. Chen, R., Lee, W.Y.W., Zhang, X.H., Zhang, J.T., Lin, S., Xu, L.L., Huang, B., Yang, F.Y., Liu, H.L., Wang, B., Tsang, L.L., Willaime-Morawek, S., Li, G., Chan, H.C., & Jiang X. (2017). Epigenetic Modification of the CCL5/CCR1/ERK Axis Enhances Glioma Targeting in Dedifferentiation-Reprogrammed BMSCs. Stem Cell Reports, 8(3), 743-757.
  11. Liu, Z., Guo, J., Wang, Y., Weng, Z., Huang, B., Mei, K.Y., Zhang, X., Yuan, P., Zhao, H., Chan, W.Y., Jiang, X.*, & Chan, H.C.* (2017). CFTR-β-catenin interaction regulates mouse embryonic stem cell differentiation and embryonic development. Cell Death Diff, 24(1), 98-110.
  12. Wang, B., Lee, Y.W., Huang, B., Zhang, J., Wu, T., Jiang, X., Wang, R., & Li G. (2016). Secretome of human fetal mesenchymal stem cell ameliorates replicative senescence. Stem Cells Dev, 25(22), 1755-1766.
  13. Meng, F., Xu, L., Huang, S., Liu ,Y., Hou, Y., Wang, K., Jiang, X.*, & Li, G.* (2016). Small nuclear ribonucleoprotein polypeptide N (Sm51) promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating Runx2. Cell and Tissue Research, 366(1), 155-162.
  14. Zhang, J., Weng, Z., Tsang, K., Tsang, L., Chan, H.C., & Jiang, X. (2016). MycN is critical for the maintenance of human embryonic stem cell-derived neural crest stem cells. Plos One, 11(1), e0148062.
  15. Chen, K., Huang, B., Liu, Q., Sun, Y., & Jiang, X. (2015). Mesenchymal stem cell therapy for inflammatory bowel diseases: promise and challenge. Curr Stem Cell Res Ther, 10(6), 499-508.
  16. Tu, J., Ng, S.H., Luk, A.C.S., Liao, J., Jiang, X., Feng, B., Mak, K.K.L., Rennert, O.M., Chan, W.Y., & Lee, T.L. (2015). MicroRNA-29b/Tet1 regulatory axis epigenetically modulates mesendoderm differentiation in mouse embryonic stem cells. Nucleic Acids Res, 43(16), 7805-22. 
  17. Rui, Y., Xu, L., Chen, R., Zhang, T., Lin, S., Hou, Y., Liu, Y., Meng, F., Liu, Z., Ni, M., Tsang, K.S., Yang, F., Wang, C., Chan, H.C., Jiang, X.*, & Li G.* (2015). Epigenetic memory gained by priming with osteogenic induction medium improves osteogenesis and other properties of mesenchymal stem cells. Scientific Reports, 5, 11056.
  18. Huang, B., Li, G., & Jiang X. (2015). Fate determination in Mesenchymal Stem Cells: a perspective from histone modifying enzymes. Stem Cell Res Ther, 6(1), 35.
  19. Xu, L., Huang, S., Hou, Y., Liu, Y., Ni, M., Meng, F., Wang, K., Rui, Y., Jiang, X., & Li, G. (2015). Sox11-modified mesenchymal stem cells (MSCs) accelerate bone fracture healing: Sox11 regulates differentiation and migration of MSCs. FASEB Journal, 29(4), 1143-52.
  20. Xie, C.#, Jiang, X.#, Zhang, J.T., Sun, T.T., Sanders, A.J., Diao, R.Y., Wang, Y., Tsang, L.L., Yu, M.K., Fok, K.L., Zhang, X.H., Chung, Y.W., Ye, L., Dong, J.D., Zhao, M.Y., Guo, J.H., Lan, H.Y., Ng, C.F., Cai, Z.M., Jiang, W.G., & Chan, H.C. (2013). CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene, 32(18), 2282-91.

    * Co-corresponding author 
    # Co-first author
  1. RGC - General Research Fund [PI; 01-Jan-20]: "Jmjd1a regulates mitochondrial function of adult neural stem cells and brain aging via PI3K/AKT/mTOR pathway" (HK$1,114,025).
  2. 廣東省自然科學基金 (基礎與應用基礎研究方向)項目 [PI; 29-Mar-19]: "新型間充質幹細胞治療兒童缺血缺氧性腦病的應用研究" (RMB500,000).
  3. National Natural Science Foundation of China (NSFC) [PI; 17-Jan-18]: "組蛋白去甲基化酶KDM3A和KMD4C在MSC衰老和老年性疾病中的作用和應用研究" (RMB560,000).
  4. RGC - General Research Fund [PI; 01-Sep-17 to 31-Aug-20]: "Epigenetic and functional characterization of histone demethylases Jmjd1a and Jmjd2c in MSC senescence" (HK$961,571).
  5. RGC - General Research Fund [PI; 01-Jan-17 to 31-Dec-19]: "Role of CFTR in embryonic stem cells and early embryo development: possible regulation of the Wnt/β-catenin signaling" (HK$1,056,150).
  6. Health and Medical Research Fund [PI; 01-Sep-16 to 31-Aug-18]: "Neural Crest Stem Cells: a Novel Source of Cell Therapy for Neontal Hypoxic-ischemic Brain Damage" (HK$1,195,440).
  7. RGC - General Research Fund [PI; 01-Jan-14 to 31-Dec-16]: "CFTR promotes glioma progression via suppression of p53/miR-34a pathway" (HK$840,051).
  8. Health and Medical Research Fund [PI; 01-Jan-14 to 30-Jun-16]: "Rescuing Neonates from Hypoxic-ischemic Brain Injury with Dedifferentiation-resprogrammed Mesenchymal Stem Cells" (HK$1,000,000).